Key facts
- This page summarizes Nasim Afsarmanesh's Form 4 filing for CERNER Corp.
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 09 Jun 2022, 17:20.
Nasim Afsarmanesh - 08 Jun 2022 Form 4 Insider Report for CERNER Corp
- Reporting relationship
- EVP & Chief Health Officer
- Issuer ticker
- N/A
- Reported as of
- 08 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Jun 2022, 17:20:56 UTC
- Prior SEC filing
- 08 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shane M. Dawson, by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Nasim Afsarmanesh filed Form 4 for CERNER Corp on 09 Jun 2022.
Change
- Previous filing in this sequence was filed on 08 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CERN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 08 Jun 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CERN
transaction
Derivative
Restricted Stock Units
Disposed to Issuer
- Transaction value
- Shares
- -6,444
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 08 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,444
- Exercise price
- Footnotes
- F1, F2
CERN
transaction
Derivative
Restricted Stock Units
Disposed to Issuer
- Transaction value
- Shares
- -8,024
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 08 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,024
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Nasim Afsarmanesh is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
This Form 4 reports derivative securities disposed of pursuant to the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle.
Footnote F2
At the Effective Time, each unvested restricted stock unit ("RSU") was assumed by Oracle and converted into a number of Oracle RSUs based on the Award Exchange Ratio (as defined in the Merger Agreement), on the same vesting terms, all in accordance with the Merger Agreement. Each RSU that vested on the Effective Time was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement) in accordance with the Merger Agreement. The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K.
SEC remarks
By virtue of the Merger Agreement, the reporting person has ceased being a Section 16 officer of Cerner Corporation.